Background: To ascertain service users level of knowledge regarding use of enema therapy and to investigate the need for the provision of a structured self management program. Methods: Patients were identified at the Inflammatory Bowel Disease (IBD) clinic in a tertiary referral centre and asked to participate in a confidential questionnaire. The purpose was twofold to assess patient knowledge and to identify barriers to compliance/adherence. Data were gathered prospectively over a 28 day study period and statistically analyzed. P values <0.05 were deemed significant. Results: Thirty-five completed questionnaires were received; 65.7% had Ulcerative Colitis; median age was 36; median time since diagnosis was 7 years; 94.2% had previously been prescribed topical therapy. There was no significant preference for use of liquid, foam or suppository preparations. The most widely used preparation was Salofalk enema (30.3%), followed by Predfoam (26.8%). 73% chose evening as the best time to take enemas (p < 0.0001). A large minority administered their topical treatment incorrectly, while standing (35%), with 43% adopting a left sided position. The majority (71.44%) stayed lying ten minutes or longer after administration rather than moving straight away or within 1 minute ( p < 0.017). Most patients (67.7%), did not change position once the enema had been administered (p = 0.0105). Compliance was good with 94% always or sometimes completed their full course of treatment as prescribed. Less than 1/3 participants took treatment for 1 week post symptom resolution, with 42% taking their prescribed course and 30% until they felt better. In addition, 70% of patients never started treatment without consulting a medical professional (p < 0.0028), indicating a potential need for greater autonomy in decision-making around treatment for IBD patients. The majority (59.5%) chose to contact the IBD nurse when having a flare. Also promisingly, when asked if interested in learning how better to manage flares independently 100% of participants agreed that this would be a desirable option. Conclusions: While acknowledging the small sample size in our study, gaps in both knowledge and confidence have been identified in this cohort. The service users have a good compliance record and a positive interaction with health professionals (mainly the IBD Nurse). Empowering patients through an IBD Nurse Led Self Management Programme would be beneficial for patients well being and would on the long term reduce the burden on the service.
Background: To ascertain service users level of knowledge regarding use of enema therapy and to investigate the need for the provision of a structured self management program. Methods: Patients were identified at the Inflammatory Bowel Disease (IBD) clinic in a tertiary referral centre and asked to participate in a confidential questionnaire. The purpose was twofold to assess patient knowledge and to identify barriers to compliance/adherence. Data were gathered prospectively over a 28 day study period and statistically analyzed. P values <0.05 were deemed significant. Results: Thirty-five completed questionnaires were received; 65.7% had Ulcerative Colitis; median age was 36; median time since diagnosis was 7 years; 94.2% had previously been prescribed topical therapy. There was no significant preference for use of liquid, foam or suppository preparations. The most widely used preparation was Salofalk enema (30.3%), followed by Predfoam (26.8%). 73% chose evening as the best time to take enemas (p < 0.0001). A large minority administered their topical treatment incorrectly, while standing (35%), with 43% adopting a left sided position. The majority (71.44%) stayed lying ten minutes or longer after administration rather than moving straight away or within 1 minute ( p < 0.017). Most patients (67.7%), did not change position once the enema had been administered (p = 0.0105). Compliance was good with 94% always or sometimes completed their full course of treatment as prescribed. Less than 1/3 participants took treatment for 1 week post symptom resolution, with 42% taking their prescribed course and 30% until they felt better. In addition, 70% of patients never started treatment without consulting a medical professional (p < 0.0028), indicating a potential need for greater autonomy in decision-making around treatment for IBD patients. The majority (59.5%) chose to contact the IBD nurse when having a flare. Also promisingly, when asked if interested in learning how better to manage flares independently 100% of participants agreed that this would be a desirable option. Conclusions: While acknowledging the small sample size in our study, gaps in both knowledge and confidence have been identified in this cohort. The service users have a good compliance record and a positive interaction with health professionals (mainly the IBD Nurse). Empowering patients through an IBD Nurse Led Self Management Programme would be beneficial for patients well being and would on the long term reduce the burden on the service. Background: Little information is available on the perceived level of patient satisfaction with the quality of care received in specialist inflammatory bowel disease (IBD) units. The objective of this study was to assess the perceived level of patient satisfaction with the care received from staff at the IBD unit by means of a questionnaire. Methods: In this prospective single-centre study, a questionnaire was drawn up to assess the perceived satisfaction of patients with the care received in programmed visits, open access visits, open access phone calls, emergency room visits, day hospital visits and hospitalization. The questionnaire comprised 16 questions covering these 6 types of care. For each question, a 5-point Likert scale was used, with scores ranging from full agreement (5 points) to full disagreement (1 point). The relevance and reliability of the questionnaire were assessed by a panel of 3 experts. After validation in 10 patients, the questionnaire was administered during a 2-week period in 2011 to patients with confirmed diagnosis of IBD and in followup for more than 1 year in the IBD unit. The statistical analysis was performed with the SPSS 16.0 statistical package. Results: In total, 121 questionnaires were completed; 5% of these were discarded because the patient had been in follow-up in the unit for less than 1 year and a further 5% were discarded because the patients had visual/cognitive deficit and/or they refused to fill out the questionnaire. The mean (SD) age was 45 (13) years, the mean duration of disease was 11.5 (9.1) years, and the mean duration in follow-up in the unit was 8 (6.6) years. Crohn's disease was reported in 62.5% and ulcerative colitis in 29%, while 83.1% were in active employment. 38% had studied at university and 35% had completed secondary school. Background: Nurse prescribing improves the quality of patient care, with timely access to drugs and reduction in physician dependence(1). Role descriptives for IBD nurse specialists (IBDNS) encourage nurse prescribing to enhance patient based services(2). Methods: To determine the current prescribing practice of IBDNS in a single centre. All prescribing events (PxE) were recorded by 2 IBDNS prospectively for 3 months. A PxE included; new drug, repeat prescription or dose change. Decision-making was recorded as independant initiation by IBDNS +/-physician discussion, consensus decision, initiation by physician. Drugs were classified as anti-TNF therapies, immunomodulators (IM) (thiopurines, methotrexate), oral corticosteroids (CS), oral5ASA and topical therapies (TT). Results: Of 231 patients studied, 279 PxE were recorded (118 ulcerative colitis; 107 Crohn's disease; 3 indeterminate and 3 lymphocytic colitis). Median age was 42 years (range 18 89); 102 (44.2%) male. There was a mean of 1.5 events/day/IBDNS. One hundred and fifty (65%) patients had a PxE at contact specific to IBDNS; 108 (47%) phone; 42 (18%) at scheduled IM or biological therapy. In 81 (35%), this occurred at a scheduled outpatient visit. The majority, 135 (58%) had active disease at PxE. In these, 178 PxE occurred: TT 46 (26%); CS 39 (22%); IM 26 (15%); anti TNF 24 (13%), oral5ASA 23 (13%), and non-IBD drugs 20 (11%). In those with inactive disease (n = 96), there were significantly fewer PxE for TT (p < 0.001), and CS (p < 0.001). There were Downloaded from https://academic.oup.com/ecco-jcc/article-abstract/6/Supplement_1/S198/369439 by guest on 04 February 2019
